Celina Chew is a qualified lawyer by training, having graduated from the University of Western Australia and University of Hong Kong. She was named in Forbes’ China 100 Most Powerful Businesswomen Lists of 2017 and 2018.
Ms Chew will commence as vice president of business development at biotechnology company Argenica Therapeutics in December 2023. Prior to that, she spent 5 years as president for Greater China area at global life sciences company Bayer, head of Bayer’s North ASEAN Region, and 14 years as their general counsel in Greater China where she advised the company on investments, acquisitions and operations in Greater China. She had also worked on a number of commercial deals for the company in Asia.